Assetmark, Inc Corcept Therapeutics Inc Transaction History

Assetmark, Inc

$45.6 Billion
Q3 2025

A detailed history of Assetmark, Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Assetmark, Inc holds 64,726 shares of CORT stock, worth $4.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

64,726

Previous 61,765 4.79%

Holding current value

$4.89 Million

Previous $4.53 Million 18.66%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$67.17 - $83.9 $198,890 - $248,427	2,961 Added 4.79%	64,726 $5.38 Million
Q2 2025 Aug 04, 2025	SELL	$62.24 - $91.93 $574,164 - $848,054	-9,225 Reduced 12.99%	61,765 $4.53 Million
Q1 2025 May 06, 2025	BUY	$49.85 - $114.22 $718,488 - $1.65 Million	14,413 Added 25.48%	70,990 $8.11 Million
Q4 2024 Feb 06, 2025	SELL	$44.66 - $60.85 $300,740 - $409,763	-6,734 Reduced 10.64%	56,577 $2.85 Million
Q3 2024 Nov 01, 2024	BUY	$29.51 - $46.26 $36,444 - $57,131	1,235 Added 1.99%	63,311 $2.93 Million

Q2 2024 Aug 13, 2024	BUY	$22.21 - $34.48 $113,271 - $175,847	5,100 Added 8.95%	62,076 $2.02 Million
Q1 2024 May 06, 2024	BUY	$21.1 - $27.46 $18,462 - $24,027	875 Added 1.56%	56,976 $1.44 Million
Q4 2023 Feb 09, 2024	BUY	$24.82 - $32.88 $959,888 - $1.27 Million	38,674 Added 221.92%	56,101 $1.82 Million
Q3 2023 Oct 27, 2023	SELL	$21.97 - $33.8 $596,463 - $917,636	-27,149 Reduced 60.9%	17,427 $474,000
Q2 2023 Aug 11, 2023	BUY	$21.44 - $25.15 $54,907 - $64,409	2,561 Added 6.1%	44,576 $991,000
Q1 2023 May 05, 2023	BUY	$19.2 - $24.47 $63,840 - $81,362	3,325 Added 8.59%	42,015 $910,000
Q4 2022 Feb 10, 2023	BUY	$19.95 - $29.96 $21,725 - $32,626	1,089 Added 2.9%	38,690 $785,000
Q3 2022 Nov 01, 2022	BUY	$24.7 - $29.12 $15,314 - $18,054	620 Added 1.68%	37,601 $964,000
Q2 2022 Aug 03, 2022	BUY	$17.33 - $25.3 $58,748 - $85,767	3,390 Added 10.09%	36,981 $879,000
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $69,673 - $106,260	-4,215 Reduced 11.15%	33,591 $756,000
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $445,762 - $608,427	-26,068 Reduced 40.81%	37,806 $749,000
Q3 2021 Nov 12, 2021	BUY	$19.68 - $22.53 $124,279 - $142,276	6,315 Added 10.97%	63,874 $1.26 Million
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $584,282 - $714,772	29,258 Added 103.38%	57,559 $1.27 Million
Q1 2021 May 14, 2021	BUY	$23.49 - $30.56 $53,040 - $69,004	2,258 Added 8.67%	28,301 $673,000
Q4 2020 Feb 10, 2021	SELL	$16.78 - $27.3 $361,441 - $588,042	-21,540 Reduced 45.27%	26,043 $681,000
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $479,722 - $769,249	38,501 Added 423.93%	47,583 $828,000
Q2 2020 Aug 11, 2020	BUY	$11.0 - $18.26 $99,902 - $165,837	9,082 New	9,082 $153,000

Others Institutions Holding CORT

# of Institutions

480

Shares Held

80.5M

Call Options Held

596K

Put Options Held

710K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $8.09B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account